
- /
- Supported exchanges
- / SA
- / FLRY3.SA
Fleury S.A. (FLRY3 SA) stock market data APIs
Fleury S.A. Financial Data Overview
Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and imaging tests, genomics, health management and platform, diagnostic information, check-up and reference laboratory, clinic day, infusion center, orthopedics and ophthalmology, dental imaging tests, and diagnostic imaging services. The company also offers Saúde I, a digital healthcare platform that provides services, including scheduling and performing teleconsultations, and face-to-face consultations, as well as scheduling and accessing diagnostic test results, electronic medical record, and self-manage health issues. It operates customer service units and hospital-based units under the Fleury, Felippe Mattoso, Labs a+, Diagnoson a+, Papaiz, Serdil, LAFE, Instituto de Radiologia de Natal, Centro de Patologia Clínica, Diagmax, Santécorp, a+SP, CIP, Saha, Moacir Cunha, Vita, e Campana, Methodos, Pretti, Bioclinico, a+PE, Marcelo Magalhaes, Inlab, Weinmann, a+, a+BA, IRN, CPC, and a+PI brand names. The company was founded in 1926 and is headquartered in São Paulo, Brazil.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Fleury S.A. data using free add-ons & libraries
Get Fleury S.A. Fundamental Data
Fleury S.A. Fundamental data includes:
- Net Revenue: 7 795 M
- EBITDA: 1 748 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-03-31
- EPS/Forecast: 0.3328
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Fleury S.A. News

Fleury SA (BSP:FLRY3) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Gross Revenue: BRL2 billion in Q4 2024, an increase of 8.7% compared to Q4 2023. Annual Gross Revenue: BRL8.3 billion for 2024, a growth of 19.5% over 2023. EBITDA: BRL405.75 million in Q4 2024, up 7....


Fleury SA (BSP:FLRY3) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market ...
Gross Revenue: BRL 2.1 billion, an increase of 6.1% compared to Q3 2023. EBITDA: BRL 347 million, a growth of 6.2% with a margin of 27.4%. Net Income: BRL 190.7 million, an increase of 9.5% with a net...

Miami F1 race a big boon for the sport — and for big brands
It was a thrilling end to the inaugural Miami F1 Grand Prix, in which Red Bull F1 driver Max Verstappen took the win despite a Ferrari (RACE) lockout of the first row of the grid after qualifying. Aft...

Those who invested in Monster Beverage (NASDAQ:MNST) five years ago are up 82%
Stock pickers are generally looking for stocks that will outperform the broader market. And in our experience, buying the right stocks can give your wealth a significant boost. For example, long term ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.